tiprankstipranks
Advertisement
Advertisement

AUPH Stock Latest News

Aurinia Pharmaceuticals price target raised to $16 from $15 at RBC Capital
The FlyAurinia Pharmaceuticals price target raised to $16 from $15 at RBC Capital
4h ago
AUPH
Aurinia Posts Strong Q2 2026 Results on Rising LUPKYNIS Sales
PremiumCompany Announcements
Aurinia Posts Strong Q2 2026 Results on Rising LUPKYNIS Sales
1d ago
AUPH
Aurinia Posts Strong Q2 Results, Reaffirms 2026 Outlook and Advances Autoimmune Pipeline
PremiumCompany Announcements
Aurinia Posts Strong Q2 Results, Reaffirms 2026 Outlook and Advances Autoimmune Pipeline
1d ago
AUPH
Aurinia Pharmaceuticals sees FY26 revenue $315M-$325M, consensus $325.82M
PremiumThe Fly
Aurinia Pharmaceuticals sees FY26 revenue $315M-$325M, consensus $325.82M
1d ago
AUPH
Aurinia Pharmaceuticals reports Q2 EPS 28c, consensus 24c
PremiumThe Fly
Aurinia Pharmaceuticals reports Q2 EPS 28c, consensus 24c
1d ago
AUPH
Aurinia Targets Myasthenia Gravis With New Aritinercept Trial, Expanding Its Growth Story
PremiumCompany AnnouncementsAurinia Targets Myasthenia Gravis With New Aritinercept Trial, Expanding Its Growth Story
4d ago
AUPH
Aurinia Pharmaceuticals (AUPH) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Aurinia Pharmaceuticals (AUPH) Q2 Earnings Cheat Sheet
10d ago
AUPH
Aurinia Pharmaceuticals announces initiation of PRESERVE study
Premium
The Fly
Aurinia Pharmaceuticals announces initiation of PRESERVE study
1M ago
AUPH
Aurinia’s PRESERVE Trial: New Combination Strategy for Lupus Nephritis in Focus
PremiumCompany Announcements
Aurinia’s PRESERVE Trial: New Combination Strategy for Lupus Nephritis in Focus
2M ago
AUPH
Aurinia Shareholders Back Board Slate and Governance Measures
PremiumCompany Announcements
Aurinia Shareholders Back Board Slate and Governance Measures
2M ago
8K
AUPH
Aurinia presents new analysis of AURORA 1 Phase 3 study of Lupkynis
PremiumThe Fly
Aurinia presents new analysis of AURORA 1 Phase 3 study of Lupkynis
2M ago
AUPH
Morning Movers: Macy’s and Medtronic rise after quarterly reports
PremiumThe Fly
Morning Movers: Macy’s and Medtronic rise after quarterly reports
2M ago
M
GME
Aurinia Pharmaceuticals up 4% in pre-market after insider transactions
PremiumThe FlyAurinia Pharmaceuticals up 4% in pre-market after insider transactions
2M ago
AUPH
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences
Premium
Company Announcements
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences
3M ago
8K
AUPH
Aurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c
Premium
The Fly
Aurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c
3M ago
AUPH
Aurinia backs FY26 revenue view $315M-$325M, consensus $326.22M
PremiumThe Fly
Aurinia backs FY26 revenue view $315M-$325M, consensus $326.22M
3M ago
AUPH
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
PremiumCompany Announcements
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
4M ago
8K
AUPH
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
PremiumThe Fly
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
4M ago
KZR
AUPH
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
PremiumThe Fly
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
4M ago
IQ
SR
Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
PremiumCompany AnnouncementsAurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
4M ago
AUPH
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
Premium
The Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
4M ago
KZR
AUPH
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
Premium
The Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
4M ago
KZR
AUPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >